Author
Listed:
- Gloria V. Echeverria
(The University of Texas MD Anderson Cancer Center)
- Emily Powell
(The University of Texas MD Anderson Cancer Center)
- Sahil Seth
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Zhongqi Ge
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Alessandro Carugo
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Christopher Bristow
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Michael Peoples
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Frederick Robinson
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Huan Qiu
(The University of Texas Health Science Center)
- Jiansu Shao
(The University of Texas MD Anderson Cancer Center)
- Sabrina L. Jeter-Jones
(The University of Texas MD Anderson Cancer Center)
- Xiaomei Zhang
(The University of Texas MD Anderson Cancer Center)
- Vandhana Ramamoorthy
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Shirong Cai
(The University of Texas MD Anderson Cancer Center)
- Wenhui Wu
(The University of Texas MD Anderson Cancer Center)
- Giulio Draetta
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Stacy L. Moulder
(The University of Texas MD Anderson Cancer Center)
- William F. Symmans
(The University of Texas MD Anderson Cancer Center)
- Jeffrey T. Chang
(The University of Texas MD Anderson Cancer Center
The University of Texas Health Science Center)
- Timothy P. Heffernan
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Helen Piwnica-Worms
(The University of Texas MD Anderson Cancer Center)
Abstract
Most triple negative breast cancers (TNBCs) are aggressively metastatic with a high degree of intra-tumoral heterogeneity (ITH), but how ITH contributes to metastasis is unclear. Here, clonal dynamics during metastasis were studied in vivo using two patient-derived xenograft (PDX) models established from the treatment-naive primary breast tumors of TNBC patients diagnosed with synchronous metastasis. Genomic sequencing and high-complexity barcode-mediated clonal tracking reveal robust alterations in clonal architecture between primary tumors and corresponding metastases. Polyclonal seeding and maintenance of heterogeneous populations of low-abundance subclones is observed in each metastasis. However, lung, liver, and brain metastases are enriched for an identical population of high-abundance subclones, demonstrating that primary tumor clones harbor properties enabling them to seed and thrive in multiple organ sites. Further, clones that dominate multi-organ metastases share a genomic lineage. Thus, intrinsic properties of rare primary tumor subclones enable the seeding and colonization of metastases in secondary organs in these models.
Suggested Citation
Gloria V. Echeverria & Emily Powell & Sahil Seth & Zhongqi Ge & Alessandro Carugo & Christopher Bristow & Michael Peoples & Frederick Robinson & Huan Qiu & Jiansu Shao & Sabrina L. Jeter-Jones & Xiaom, 2018.
"High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer,"
Nature Communications, Nature, vol. 9(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-07406-4
DOI: 10.1038/s41467-018-07406-4
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Louise A. Baldwin & Nenad Bartonicek & Jessica Yang & Sunny Z. Wu & Niantao Deng & Daniel L. Roden & Chia-Ling Chan & Ghamdan Al-Eryani & Damien J. Zanker & Belinda S. Parker & Alexander Swarbrick & S, 2022.
"DNA barcoding reveals ongoing immunoediting of clonal cancer populations during metastatic progression and immunotherapy response,"
Nature Communications, Nature, vol. 13(1), pages 1-18, December.
- F. Nadalin & M. J. Marzi & M. Pirra Piscazzi & P. Fuentes-Bravo & S. Procaccia & M. Climent & P. Bonetti & C. Rubolino & B. Giuliani & I. Papatheodorou & J. C. Marioni & F. Nicassio, 2024.
"Multi-omic lineage tracing predicts the transcriptional, epigenetic and genetic determinants of cancer evolution,"
Nature Communications, Nature, vol. 15(1), pages 1-23, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-07406-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.